Aktie A0YJW7 ZEALAND PHARMA A/S
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Zealand Pharma A/S

Aktien

A0YJW7

DK0060257814

ZEAL

Markt geschlossen - Nasdaq Copenhagen
Andere Börsenplätze
 16:59:42 28.05.2024 		% 5 Tage % 1. Jan.
614.5 DKK -0.41% Intraday Chart für Zealand Pharma A/S -1.29% +64.66%
23.05. Zealand Pharma gibt Topline-Ergebnisse der mechanistischen Dream-Studie mit niedrigen Dosen des GLP-1/GLP-2-Rezeptor-Dualagonisten Dapiglutid bekannt CI
16.05. Transcript : Zealand Pharma A/S, Q1 2024 Earnings Call, May 16, 2024

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
El ensayo del fármaco contra la obesidad de Zealand Pharma decepciona, pero los próximos datos son clave -- Market Talk
Zealand Pharma A/S : announces topline results from the mechanistic investigator led DREAM trial with low doses of GLP 1/GLP 2 receptor dual agonist dapiglutide
Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutide
Zealand Pharma Announces Topline Results from the Mechanistic Investigator-Led Dream Trial with Low Doses of GLP-1/GLP-2 Receptor Dual Agonist Dapiglutide
Nordic Stocks Declined Thursday; Zealand Pharma Took Biggest Hit
Zealand Pharma A/S : Q1 2024 Financial Results
Zealand Pharma Announces Financial Results for the First Quarter of 2024
Zealand Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial results
Novo Nordisk y Eli Lilly caen : AmGen avanza con un medicamento contra la obesidad
Zealand Pharma A/S : Correction to Company announcement - No. 23 / 2024
Correction to Company announcement – No. 23 / 2024
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024
U.S. Futures Up, European Stocks Flat as Powell Reiterates Room for Rate Cuts This Year
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
Zealand Pharma major shareholder announcement: Van Herk Investments
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0YJW7 Aktie
  4. Nachrichten Zealand Pharma A/S
  5. Andere Sprachen